Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-20 · accession 0001062993-21-007849 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-20 | 2021-08-20 | SRTA | PHILIP EDWARD M | Dir | A - Grant | $0.00 | +54.7K | 54.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2021-08-20 | A | A | 54,669 | $0.00 | 54,669 | D | — | — | (F1) Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 22,510 of the RSUs will vest on a basis of 25% each three months measured from May 7, 2021, subject to the Reporting Person's continued service to the Company through the applicable vesting date or the end of the Reporting Person's current term as a director of the Issuer. The remaining RSUs will vest on May 7, 2023, subject to the Reporting Person's continued service to the Issuer through the earlier of (i) the end of the Reporting Person's current term as a director and (ii) May 7, 2023. |